H2G heads into May with a fresh AGM mandate and a full-year earnings print that shows real — if early — commercial progress.
The most important development this week was Wednesday's annual general meeting, which shareholders backed strongly. That vote of confidence comes at a micro-cap inflection point: the company's full-year 2025 results, reported in late February, showed revenue jump to AUD 1.37 million from just AUD 90,000 a year earlier — a more than fifteen-fold increase. Net loss narrowed to AUD 974,000 from AUD 1.16 million. Basic loss per share improved to AUD 0.0015 from AUD 0.0024. The numbers are tiny in absolute terms, but the trajectory is moving in the right direction.
Price action tells a more cautious story. The stock closed Wednesday at AUD 0.011, down 8.3% on the day and flat over the prior week and month. At AUD 1.1 cents, this is a deeply speculative name. No short interest data is available for H2G — a function of its size and limited borrowable supply — so positioning analysis is largely absent. The EV sits at roughly AUD 7.7 million, consistent with a company at the earliest stages of commercialisation. There is no dividend and no yield story here.
Ownership is tightly held. Executive Chairman Paul Dalgleish controls 11.3% of shares outstanding. Founder Anthony Barton holds 14.3%. Guido Belgiorno-Nettis, a well-known Australian infrastructure investor, holds 7.2%. Together the top three shareholders account for roughly a third of the register. Several smaller holders added new positions at the February reporting date — Ponderosa Investments and Chembank each initiated or extended stakes — suggesting quiet accumulation among connected parties rather than broad institutional interest.
The insider trade record is stale, with the last logged activity dating to May 2024, when Dalgleish and the CFO subscribed to shares at AUD 0.006 per share in a follow-on raise. That placement price is well below the current AUD 0.011 level. A separate equity offering in early 2026 raised approximately AUD 941,000. The pattern is one of incremental, founder-anchored capital raises rather than institutional sponsorship.
Earnings reactions have been mixed. Three of the last four events produced negative next-day moves, ranging from -4% to -11%. The one positive print — a 24% one-day gain in March 2026 — coincided with the full-year results release. The next reporting event is expected around May 27. Whether that date yields confirmed earnings or a preliminary update will be the key thing to watch as the company continues its transition from near-zero revenue to a genuine operating business.
See the live data behind this article on ORTEX.
Open H2G on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
